about
Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual ScreeningGastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers.Suramin: clinical uses and structure-activity relationships.GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses.Cyclodextrin-crosslinked poly(acrylic acid): adhesion and controlled release of diflunisal and fluconazole from solid dosage forms.Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues.Efficient manual Fmoc solid-phase synthesis of the N-terminal segment of surfactant protein B (SP-B(1-25)).Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs).Cyclodextrin-crosslinked poly(acrylic acid): Synthesis, physicochemical characterization and controlled release of diflunisal and fluconazole from hydrogels.Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: correlation with hemolytic potency and implications for drug delivery.Metal chelation, radical scavenging and inhibition of Aβ₄₂ fibrillation by food constituents in relation to Alzheimer's disease.Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin.Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer's Disease: Synthesis, Pharmacology, and Molecular Modeling Studies.Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron(II) Chelation.Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon.Synthesis of Nickel-Chelating Fluorinated Lipids for Protein Monolayer CrystallizationsEnzyme-Responsive Controlled Release of Covalently Bound Prodrug from Functional Mesoporous Silica NanospheresStructure-Activity Relationships of GAG Mimetic-Functionalized Mesoporous Silica Nanoparticles and Evaluation of Acyclovir-Loaded Antiviral Nanoparticles with Dual Mechanisms of Action‘Click’ assembly of glycoclusters and discovery of a trehalose analogue that retards Aβ40 aggregation and inhibits Aβ40-induced neurotoxicitySaponins from Quillaja saponaria Molina: Isolation, Characterization and Ability to Form Immuno Stimulatory Complexes (ISCOMs)Caco-2 cell permeability and stability of two d-glucopyranuronamide conjugates of thyrotropin-releasing hormoneBrain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug ApproachA brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolitesSmad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signallingRationally Designed Dendritic Silica Nanoparticles for Oral Delivery of Exenatide
P50
Q27718786-FCFD5421-21CF-471A-9FEE-FC162A230033Q36320788-2D58B817-A37B-4E45-A727-ACB7D8D2C673Q37320583-531452AE-6134-4A80-AD5A-183D4ED76CE4Q40591064-5389919B-B3C3-43CA-AF5E-5852DABF20D7Q43240311-F7D365D0-34A1-4026-97E7-D79DCC9B9DD3Q44071815-03CB84E3-DC52-4177-B2CF-099EAC720920Q45929452-9C19E26D-74FF-42DD-BA5B-30ECCD7408F7Q46046486-EC4B3160-7F1A-4B20-AEDE-491D4BBFA209Q46347831-FAF47A13-1495-4A1D-A996-8202BE4011EAQ46569393-C2CA0BB6-3F2C-4D94-914D-A83D62ACDBC3Q46609783-2534BFFF-6336-41E0-A615-9860D791CFBEQ46708700-514C2882-AE11-4308-BF89-F810394C6312Q47641908-52D58B5C-B258-4998-BC62-7A94890D946DQ47684011-13E3C0AD-2070-4C04-8CF1-A936DDF2C1EBQ48172747-A0DE930D-A273-47BB-B8CB-83605F94B8E2Q57055333-B420ACD4-553C-4AFE-A648-9294CA416211Q57341831-D6E5B94F-9436-44D8-ACAC-27D99C89EBC8Q59356504-D326389E-749D-4CFD-8CC4-8732924516AEQ61970635-E4EC4C10-67FB-44DE-B6E6-B2813833AC09Q61970657-B914CBE1-7397-41D9-9909-43F545B1F61AQ80325597-1AC4A7E1-D15E-4ACD-9D15-092377360B24Q92026251-EAD44691-56AF-4F6F-8E37-C4D9CBEAF784Q92357959-2B78E95D-3311-4720-B4FD-3DCA25F3958BQ92583270-4DE307C0-DA97-4381-8BEF-B6D25D94DC9EQ92730565-8A970A30-4EDE-4D37-8486-6A733C164669
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Benjamin P Ross
@ast
Benjamin P Ross
@en
Benjamin P Ross
@es
Benjamin P Ross
@nl
type
label
Benjamin P Ross
@ast
Benjamin P Ross
@en
Benjamin P Ross
@es
Benjamin P Ross
@nl
prefLabel
Benjamin P Ross
@ast
Benjamin P Ross
@en
Benjamin P Ross
@es
Benjamin P Ross
@nl
P106
P1153
7401608823
P31
P496
0000-0002-1899-8484